Radio Frequency Identification (RFID) In Pharmaceuticals Market Report 2026

Radio Frequency Identification (RFID) In Pharmaceuticals Market Overview

• Radio Frequency Identification (RFID) In Pharmaceuticals market size has reached to $6.08 billion in 2025 • Expected to grow to $10.07 billion in 2030 at a compound annual growth rate (CAGR) of 10.6% • Growth Driver: Surge In Counterfeit Drug Incidents Fuelling The Growth Of The RFID In Pharmaceuticals Market Due To Rising Online Pharmacy Penetration • Market Trend: Advancing Medication Safety And Supply Chain Integrity With RFID Integration • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Radio frequency identification (RFID) in pharmaceuticals is a wireless technology that uses electronic tags with chips and antennas to automatically identify, track, and manage medicines throughout the entire supply chain, from manufacturing to the end use. This technology enhances patient safety, ensures regulatory compliance, and streamlines operations by allowing rapid, contactless, and accurate verification of drug authenticity and movement at every stage. The main type of radio frequency identification (RFID) in the pharmaceuticals includes chipped radio frequency identification and chipless radio frequency identification. Chipped radio frequency identification refers to radio frequency identification (RFID) technology that uses tags embedded with microchips and antennas, allowing for the storage and wireless transmission of unique identification data, tracking information, and product history, which can be read by compatible radio frequency identification (RFID) readers for real-time authentication, monitoring, and management of pharmaceutical products across the supply chain. These are supported by various components such as radio frequency identification tags, radio frequency identification readers, middleware software, integration services, and data management software, and are deployed in line with regulatory compliance standards including food and drug administration compliance standards, european union falsified medicines directive, good distribution practices, serialization requirements, and tracking and tracing regulations. Radio frequency identification technologies are used across several applications, which include drug track and trace systems, asset tracking, patient safety, and other relevant uses, serving a wide range of end users such as pharmaceutical manufacturers, hospitals and healthcare providers, pharmacies and drug wholesalers, research and development laboratories, and logistics and supply chain companies.

What Is The Radio Frequency Identification (RFID) In Pharmaceuticals Market Growth Forecast?

The radio frequency identification (rfid) in pharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $10.07 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing investments in digital pharmaceutical logistics, rising demand for real-time supply chain visibility, expansion of rfid-enabled smart hospitals, growing adoption of blockchain-linked traceability systems, increasing regulatory harmonization across regions. Major trends in the forecast period include increasing adoption of end-to-end drug track and trace systems, rising use of rfid for anti-counterfeiting measures, growing integration of rfid with serialization platforms, expansion of real-time pharmaceutical inventory visibility, enhanced focus on cold chain monitoring accuracy.

Global Radio Frequency Identification (RFID) In Pharmaceuticals Market Segmentation

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification 2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software 3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations 4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications 5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies Subsegments: 1) By Chipped Radio Frequency Identification: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification 2) By Chipless Radio Frequency Identification: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

What Is The Driver Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The increasing incidences of counterfeit drugs are expected to propel the growth of radio frequency identification (RFID) in pharmaceuticals market going forward. Counterfeit drugs, also known as counterfeit medicines, are pharmaceutical products that are deliberately and fraudulently mislabeled with respect to their identity or source. The increasing incidences of counterfeit drugs are due to the rapid growth of online pharmacies, which has made it easier for counterfeiters to distribute fake medicines directly to consumers, bypassing traditional regulatory safeguards and making detection more difficult. Radio frequency identification (RFID)in pharmaceuticals supports the fight against counterfeit drugs by providing secure, traceable data that verifies product authenticity at every stage of the supply chain. For instance, in December 2024, according to the American Chemical Society, a US-based nonprofit scientific society, there were 6,987 reported counterfeit drug incidents across 142 countries in 2023, representing an increase of 4% from 2022. Therefore, the increasing incidences of counterfeit drugs are driving the growth of radio frequency identification (RFID) in pharmaceuticals industry.

Key Players In The Global Radio Frequency Identification (RFID) In Pharmaceuticals Market

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Global Radio Frequency Identification (RFID) In Pharmaceuticals Market Trends and Insights

Major companies operating in the radio frequency identification (RFID) in pharmaceuticals market are focusing on the development of advanced RFID-enabled labels to enhance product traceability, improve inventory management, and combat the growing threat of counterfeit drugs. RFID-enabled labels are smart tags that use radio frequency technology to wirelessly identify, track, and verify pharmaceutical products throughout the supply chain. For instance, in May 2023, Fresenius Kabi AG, a Germany-based pharmaceutical company, launched the Rocuronium Bromide Injection with advanced RFID-enabled labeling to enhance medication tracking, inventory management, and patient safety in healthcare facilities. It is supplied as a 50 mg per 5 mL multiple-dose vial for intravenous administration by trained medical professionals. The injection features advanced RFID-enabled smart labeling, which enables real-time tracking, streamlines inventory management, and helps reduce medication errors.

What Are Latest Mergers And Acquisitions In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

In April 2023, Impinj Inc., a US-based technology company, acquired Voyantic Ltd for an undisclosed amount. Through this acquisition, Impinj Inc. aims to strengthen its position in the radio frequency identification industry and enhance its portfolio with advanced radio frequency identification testing and measurement solutions for improved performance and innovation. Voyantic Ltd. is a Finland-based company that provides radio frequency identification testing, measurement, and quality assurance solutions for radio frequency identification tags and systems in pharmaceuticals.

Regional Outlook

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The radio frequency identification (RFID) in pharmaceuticals market consists of revenues earned by entities providing services such as drug authentication, real-time tracking and tracing of medications, inventory management, anti-counterfeiting solutions, and regulatory compliance. The market value includes the value of related goods sold by the service provider or included within the service offering. The radio frequency identification (RFID) in pharmaceuticals market also includes sales of fixed readers, tracing systems, and verification systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Radio Frequency Identification (RFID) In Pharmaceuticals Market Report 2026?

The radio frequency identification (rfid) in pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the radio frequency identification (rfid) in pharmaceuticals industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.